Synthesis and evaluation of new potent inhibitors of CK1 and CDK5, two kinases involved in Alzheimer's disease

L Demange, O Lozach, Y Ferandin, NT Hoang…

Index: Demange, Luc; Lozach, Olivier; Ferandin, Yoan; Hoang, Nha Thu; Meijer, Laurent; Galons, Herve Medicinal Chemistry Research, 2013 , vol. 22, # 7 p. 3247 - 3258

Full Text: HTML

Citation Number: 4

Abstract

Abstract Cyclin-dependent kinase 5 (CDK5) and Casein kinase 1 (CK1) are both involved in the hyperphosphorylation of the Tau protein and in the amyloid-β production, the two major hallmarks of Alzheimer's disease. In the present paper, we describe the synthesis and biological evaluation of new series of 2, 6, 9-trisubstituted purines derived from DRF53, a dual specificity inhibitor of the kinase activity of CDK5 (IC 50= 80 nM) and CK1 (IC 50= 10 ...

Related Articles:

Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1

[Oumata, Nassima; Bettayeb, Karima; Ferandin, Yoan; Demange, Luc; Lopez-Giral, Angela; Goddard, Marie-Lorene; Myrianthopoulos, Vassilios; Mikros, Emmanuel; Flajolet, Marc; Greengard, Paul; Meijer, Laurent; Galons, Herve Journal of Medicinal Chemistry, 2008 , vol. 51, # 17 p. 5229 - 5242]

More Articles...